Rare and Frequent Promoter Methylation, Respectively, of TSHZ2 and 3 Genes That Are Both Downregulated in Expression in Breast and Prostate Cancers
2011

TSHZ2 and TSHZ3 Genes in Breast and Prostate Cancers

Sample size: 12 publication 10 minutes Evidence: high

Author Information

Author(s): Yamamoto Miyako, Cid Emili, Bru Samuel, Yamamoto Fumiichiro

Primary Institution: Burnham Institute for Medical Research (BIMR)

Hypothesis

The downregulation of TSHZ2 and TSHZ3 genes may play an active role in carcinogenesis.

Conclusion

TSHZ2 and TSHZ3 genes are downregulated in breast and prostate cancers, suggesting they may act as tumor suppressor genes.

Supporting Evidence

  • TSHZ2 and TSHZ3 genes were the most frequently downregulated in breast cancer clinical specimens.
  • The methylation status of TSHZ3 correlated with its gene expression in normal and cancer cells.
  • Both genes belong to the same Teashirt family and exhibit similar expression patterns in cancer.

Takeaway

Scientists found that two genes, TSHZ2 and TSHZ3, are turned off in breast and prostate cancers, which might help cancer grow.

Methodology

The study used Systematic Multiplex RT-PCR and DNA microarray hybridization to analyze gene expression in normal and cancer cells.

Limitations

The study primarily focused on cell lines and may not fully represent the complexity of tumor biology.

Participant Demographics

The study included matched pairs of normal and tumor breast tissues from 12 patients.

Digital Object Identifier (DOI)

10.1371/journal.pone.0017149

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication